Main > HEPATOLOGY > Hepatitis C Virus Infection > Treatment > Co: USA. B. Daclatasvir

---

Co: USA. B. Daclatasvir's subsections
(*) CA Approval Date: ?
(*) USA Approval Date: 2015. 07.24
Company
NS5A Replication Complex Inhibitor
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2017. 04.25.
TradeMark
TradeMark Web-Site
UpDate: 2017. 04.29.

Co: USA. B. Daclatasvir's products
This section has no products